Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

JCAM changes management team in response to changing market environment

Tuesday, October 05, 2010
Opalesque Industry Update - James Caird Asset Management is evolving its investment team in response to the changing face of capital markets. JCAM’s believes that “Special Situations” and catalyst driven strategies will be vital to success at this point in the financial cycle and is pleased to announce the arrival of Ian Newton and Matthew Addison, both from the special situations team at Cheyne Capital.

Ian Newton joined JCAM in September 2010 from Cheyne Capital with over 17 years experience in Special Situations investment management with extensive experience in risk arbitrage and event driven opportunities.

Matthew Addison joined JCAM in September 2010 from Cheyne Capital where he had become a partner in 2007. His focus is on event-driven equities, merger arbitrage, and stressed/distressed debt strategies. Ian and Matthew join other recent hires Ali Satrap (Macro, ex Partner London Diversified) and Harald Hendrikse (Equity, ex Bank of America Merrill Lynch), Alastair Gilmour (Credit, ex Cheyne) and Pieter Staelens (High Yield Credit, ex CQS) in JCAM’s London operation. JCAM is also expanding its middle and back office teams.

“JCAM is fortunate to be growing at this time as the available talent pool is deep. The availability of top quality analysts, managers and traders has never been higher. We believe that the nature of financial markets and the investment styles providing the most compelling investment opportunities have changed for the foreseeable future and we are reflecting that view in our investment team.” said John Demaine, a JCAM partner.

JCAM, which manages the JCAM Global and the JCAM Credit Opportunities Funds, has approximately $2.5billion of assets under management and over 60 employees in the US and UK.

- FG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for